Polar Capital Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-67,188
| Closed | -$23.2M | – | 275 |
|
|
2024
Q1 | $23.2M | Buy |
67,188
+14,462
| +27% | +$5M | 0.12% | 138 |
|
|
2023
Q4 | $17M | Buy |
52,726
+11,151
| +27% | +$3.6M | 0.1% | 148 |
|
|
2023
Q3 | $14.9M | Buy |
41,575
+16,824
| +68% | +$6.03M | 0.11% | 158 |
|
|
2023
Q2 | $9.38M | Sell |
24,751
-123,156
| -83% | -$46.7M | 0.05% | 197 |
|
|
2023
Q1 | $70.9M | Buy |
147,907
+37,863
| +34% | +$18.1M | 0.46% | 62 |
|
|
2022
Q4 | $46.3M | Buy |
110,044
+6,390
| +6% | +$2.69M | 0.37% | 87 |
|
|
2022
Q3 | $43.2K | Sell |
103,654
-11,405
| -10% | -$4.76K | 0.28% | 85 |
|
|
2022
Q2 | $57K | Buy |
115,059
+3,263
| +3% | +$1.62K | 0.33% | 73 |
|
|
2022
Q1 | $63K | Buy |
111,796
+7,900
| +8% | +$4.45K | 0.28% | 83 |
|
|
2021
Q4 | $78.5K | Buy |
103,896
+1,950
| +2% | +$1.47K | 0.29% | 75 |
|
|
2021
Q3 | $76K | Sell |
101,946
-95,713
| -48% | -$71.4K | 0.31% | 73 |
|
|
2021
Q2 | $127K | Buy |
197,659
+9,765
| +5% | +$6.29K | 0.55% | 36 |
|
|
2021
Q1 | $107M | Buy |
187,894
+24,900
| +15% | +$14.2M | 0.66% | 41 |
|
|
2020
Q4 | $95M | Buy |
+162,994
| New | +$95M | 0.58% | 42 |
|